| Authors: |
Caprioli J; Department of Ophthalmology, Jules Stein Eye Institute, UCLA David Geffen School of Medicine, Los Angeles, California., Kim JH; Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland., Friedman DS; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Kiang T; Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland., Moster MR; Department of Ophthalmology, Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania., Parrish RK 2nd; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, Florida., Rorer EM; Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland., Samuelson T; Minnesota Eye Consultants, Minneapolis, Minnesota., Tarver ME; Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland., Singh K; Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California., Eydelman MB; Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland. Electronic address: malvina.eydelman@fda.hhs.gov. |
